The Patent Finder
US

Predictive and Diagnostic Methods for Prostate Cancer

US 11,613,785 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Onkosxcel Therapeutics, LLC, an earlier holder on the record. The recorded assignments below show how it moved.

Collateral for a security interest recorded Sep 11, 2024 (Oaktree Fund Administration, LLC).

Term ends Jul 4, 2039 · High confidence

Filed Jul 8, 2019 as application 16/476,420 · Granted Mar 28, 2023
Base term plus 541 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2018 2039
Clock starts
Jan 9, 2018
Term ends
Jul 4, 2039
Granted
Mar 28, 2023
base term patent term adjustment fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
541
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 541 days past its 20-year base term on prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 9, 2018, when application PCT/US2018/012876, the earliest non-provisional in its chain, was filed (this one was filed Jul 8, 2019)Jan 9, 2038High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+541 days, USPTO patent term adjustment recordJul 4, 2039High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJul 4, 2039High confidence

This family

Application PCT/US2018/012876PCT application
no patent term
no patent term
US 11,613,785this patent
Jul 2039
Jul 2039
Application 18/157,717Abandoned
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 8, 2019
Reel 49689, frame 674
Nandabalan, Krishnan; Rastelli, LucaBioxcel Therapeutics, Inc.Assignment of Assignor's Interest
Sep 11, 2024
Reel 68938, frame 906
Bioxcel Therapeutics, Inc.Oaktree Fund Administration, LLCSecurity Interest
Nov 22, 2024
Reel 69377, frame 185
Onkosxcel Therapeutics, LLCOaktree Fund Administration, LLCSecurity Interest
Aug 31, 2026
Reel 75851, frame 89
Bioxcel Therapeutics, Inc.; Onkosxcel Therapeutics, LLCOaktree Fund Administration, LLCSecurity Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited